NCT02491606View on ClinicalTrials.gov

Evaluation of Weekly Tafenoquine

PHASE2CompletedINTERVENTIONAL

Enrollment

249

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

September 30, 1997

Study Completion Date

September 30, 1998

Conditions

Malaria

Interventions

DRUG

Tafenoquine

Tafenoquine 200mg and 400 mg

OTHER

Placebo

Placebo

Sponsors

Collaborators (1)

SmithKline Beecham

All Listed Sponsors

collaborator

SmithKline Beecham

INDUSTRY

lead

U.S. Army Medical Research and Development Command

FED